FDA.reportPublic FDA data

ambrisentan 10 MG Oral Tablet [Letairis]

RxCUI
722120
RxNorm name
ambrisentan 10 MG Oral Tablet [Letairis]
Display name
ambrisentan 10 MG Oral Tablet [Letairis]
Full name
ambrisentan 10 MG Oral Tablet [Letairis]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LetairisAMBRISENTANGilead Sciences, Inc.725d4e73-6c83-477a-adc6-0ae4a133a8442026-06-22Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 722120

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
725d4e73-6c83-477a-adc6-0ae4a133a844Letairis 10 MG Oral Tablet [PSN] · ambrisentan 10 MG Oral Tablet [Letairis] [SBD] · Letairis 10 MG Oral Tablet [SY]327These highlights do not include all the information needed to use LETAIRIS ® safely and effectively. See full prescribing information for LETAIRIS. Letairis (ambrisentan) tablets, for oral use Initial U.S. Approval: 200720250822